ImmuCell

$10.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.13%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ImmuCell and other stocks, options, and ETFs commission-free!

About ICCC

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME. The listed name for ICCC is ImmuCell Corporation Common Stock.

CEO
Michael F. Brigham
Employees
54
Headquarters
Portland, Maine
Founded
1982
Market Cap
73.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
53.68K
High Today
$11.80
Low Today
$10.39
Open Price
$10.73
Volume
21.40K
52 Week High
$13.20
52 Week Low
$3.70

ICCC Earnings

-$0.11
-$0.06
-$0.02
$0.03
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
$0.03 per share
Replay Earnings Call

You May Also Like

PIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure